Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check2 days agoChange DetectedThe page now omits the notice about government funding and NIH operating status. All study details, eligibility criteria, and contacts remain unchanged.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNo significant additions or deletions were observed between the old and new screenshots; core study details appear unchanged.SummaryDifference0.3%

- Check45 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference4%

- Check52 days agoChange DetectedUpdate reflects a new software/version release (from v3.0.2 to v3.1.0).SummaryDifference0.1%

- Check66 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.